Loading clinical trials...
Loading clinical trials...
Anti-viral T-cell Therapy by Gamma Capture for High-risk Patients With Acquired or Inherited Immune Defects
Conditions
Interventions
Specific T- Lymphocytes
Locations
1
United States
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Start Date
January 8, 2024
Primary Completion Date
June 1, 2028
Completion Date
June 1, 2029
Last Updated
June 25, 2025
NCT05101213
NCT03258567
NCT05664126
NCT07294547
NCT03266627
NCT03266653
Lead Sponsor
Paul Szabolcs
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions